GOSS

Gossamer Bio

0.1753

-0.0003-0.17%

After Hours: 0.1768 +0.0015 +0.86%19:59 09/04 EDT

Daily

Weekly

Monthly

Quarterly

Yearly

OPEN/PREV CLOSE0.1527/11.39

TODAY RANGE0.1402-0.1567

VOL13.23M

MARKET CAP870.15K

52 WEEK RANGE0.1138-3.870

AVG VOL (3M)27.40M

% TURNOVER2.65%

TURNOVER0

P/E (TTM)-0.0032

% RANGE10.33%

EPS(TTM)-45.0400

P/E(FORWARD)-0.6980

P/B-0.0093

BVPS-15.3840

DIVIDEND--

P/S0.6866

BETA--

DIV YIELD0.00%

FREE FLOAT MKT CAP856.92K

SHARES OUTSTANDING6.11M

NEXT EARNINGS11/03-11/09

FREE FLOAT6.02M

LOT SIZE1

EX-DATE09/11/2026

News

Press Releases

Financial Reports

Profile

Dow Jones·32m ago
*Gossamer Bio Announces Effectiveness Of 1-for-80 Reverse Stock Split >GOSS
TipRanks·12h ago
Gossamer Bio trading halted, news pending
Dow Jones·1d ago
*Gossamer Bio Announces 1-for-80 Reverse Stock Split >GOSS
TipRanks·09/03 22:52
Gossamer Bio Lowers Stockholder Meeting Quorum Requirement
TipRanks·08/26 21:14
Gossamer Bio Amends Charter for New Preferred Financing
TipRanks·08/26 18:00
Analysts’ Opinions Are Mixed on These Healthcare Stocks: Gossamer Bio (GOSS) and Biohaven Ltd. (BHVN)
Seeking Alpha·08/21 13:19
Gossamer Bio announces up to $250M private placement
TipRanks·08/21 12:29
Gossamer Bio Secures Major Seralutinib Regulatory Financing Deal
TipRanks·08/21 12:05
Gossamer Bio announces upt to $250M structured private placement
Dow Jones·08/21 12:00
*Gossamer Bio Announces Up to $250M Structured Private Placement, Including $150M of Committed Cap, to Fund Seralutinib Through Potential FDA Approval
Dow Jones·08/14 16:46
Gossamer Bio Price Target Cut to $4.00/Share From $15.00 by Piper Sandler
Dow Jones·08/14 16:46
Gossamer Bio Is Maintained at Overweight by Piper Sandler
TipRanks·08/14 14:10
Analysts Offer Insights on Healthcare Companies: Gossamer Bio (GOSS), Nektar Therapeutics (NKTR) and Aprea Therapeutics (APRE)
TipRanks·08/14 12:17
Guggenheim Remains a Hold on Gossamer Bio (GOSS)
NASDAQ·08/13 21:15
Gossamer Bio (GOSS) Reports Q2 Loss, Tops Revenue Estimates

Same Industry

Name/Symbol

Change%

Price

Gossamer Bio

GOSS

-0.17%

0.1753

Regeneron Pharmaceuticals

REGN

-1.87%

827.72

GRDX

BIONTECH

BNTX

+0.86%

103.76

United Therapeutics Corp.

UTHR

-0.54%

487.61

Vertex Pharmaceuticals Inc

VRTX

-2.12%

546.12

Siga Technologie

SIGA

+1.86%

3.290

Moderna

MRNA

-2.23%

145.55

Charles Riv Labs Intl Inc

CRL

-1.65%

288.50

Medpace Holdings

MEDP

-0.35%

591.29

Talphera Inc

TLPH

0.00%

1.200

ICLR

China Biologic

CBPO

0.00%

119.99

Iqvia Hldgs Inc

IQV

-0.86%

256.98

MOLN

Arcturus Therape

ARCT

-2.91%

15.36

GILD

PRAH

Incyte Corp

INCY

-0.98%

126.75

APVO

Biospecifics

BSTC

+0.15%

88.53

No content on the Webull website shall be considered a recommendation or solicitation for the purchase or sale of securities, options or other investment products. All information and data on the website is for reference only and no historical data shall be considered as the basis for judging future trends.